What is Hepcinat LP®?
Hepcinat LP is sofosbuvir 400mg and ledipasvir 90mg, exclusively manufactured by Natco Pharma. The global leader in manufacturing hepatitis C treatments around the world.
Hepcinat LP is a relatively new medication for the treatment of hepatitis C and it was released to the public on December 15th 2014.
This is a blockbuster drug that many around the world were waiting for to treat hep C genotypes 1, 4 and sometimes 3. Its a one a day pill that cures hepatitis C.
Hep C treatment cost for Hepcinat LP is considerably lower than Harvoni, although molecularly identical, the costs of these treatments vary significantly. It is often referred to as the “authorized generic Harvoni”.
US FDA Approved for Import
It was approved in US, UK and Europe in November 2014 for treatment of adults with genotype 1 or 4 chronic hepatitis C, and for some people with genotype 3.
Hepcinat LP is approved by the US FDA for the treatment of hepatitis C and is manufactured by Natco Pharma. The license to manufacture this hepatitis C treatment was provided by Gilead Sciences an American company.
New and Improved Hepatitis C Treatment
Treating hepatitis C has always been difficult due to the prevailing treatment options with peg interferon and ribavirin. Many hep C patients could not tolerate the treatment, which had a high failure rate.
Today, Hepcinat LP is truly a interferon free treatment option.
Getting treated for hepatitis C reduces your chance of liver cancer and the need for a liver transplant.